Multiple cellular and molecular targets

"Multiple cellular and molecular targets" is a non-specific designation used in pharmacology and drug databases to describe therapeutic agents that lack a single, primary molecular target or those that exhibit high levels of polypharmacology. This term is frequently applied to drugs like metformin or aspirin, which influence a wide array of signaling pathways, metabolic enzymes, and transcription factors to achieve their clinical effects (Anighoro et al., 2014). In research contexts, it may also refer to complex mixtures, such as botanical extracts or broad-spectrum cytotoxic agents, where the cumulative effect is driven by interactions with numerous cellular components (Hopkins, 2008). Because this entry represents a collective group of targets rather than a distinct protein or gene, it is considered a classification placeholder rather than a canonical target molecule. From a drug development perspective, targeting multiple pathways can be advantageous for treating complex diseases like cancer or metabolic syndrome, but it also presents challenges in characterizing safety and efficacy (Peters, 2013). Consequently, this term indicates that the drug's mechanism is multifactorial and cannot be attributed to a singular receptor-ligand interaction.

Other names

Multi-target pharmacologyPolypharmacology targetsPleiotropic targetsNon-specific cellular targets

Drugs associated with this category exert their effects through the simultaneous modulation of diverse biological entities, including enzymes, receptors, ion channels, and nucleic acids, rather than a single defined target (Gupta et al., 2013).